Another target for HIF-1α is the MET oncogene, which is overexpressed in thyroid cancers, especially medullary thyroid cancer (MTC), thereby promoting angiogenesis, cellular motility, invasion, and metastasis [48,49]. This evidence concerns the gene HIF1A and medullary thyroid gland carcinoma.